Clinical Trials Sponsored by Rodríguez, Francisco Piqueras, M.D.
Total 1 results
-
Rodríguez, Francisco Piqueras, M.D.CompletedMuscular DiseasesSpain
Sponsors and Collaborators
- Plethora Solutions Ltd
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Foshan Sanshui District People's Hospital
- Iyad Naeem Muhammad, PhD
- S-Biotek Holding ApS
- Gunkang Pharmaceuticals, Inc
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Arsha Vidya Tirtha
- University of Applied Sciences Jena
- Sudimplant SAS - Groupe TBR
- Oblikue Consulting
- Paulo Sérgio Gomes Nogueira Borges
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Korea Otsuka International Asia Arab
- United States Department of Defense (DOD)
- Lilly PharmaceuticalCompany
- Julian Taylor Green
- Eurotrials Brasil Consultores Cientificos Ltda
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Rivierduinen, Centre for Personality disorders Jelgersma
- View Full List
Medical Conditions
- Brain Tumor, Primary
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Anemia Acute
- Hypothermia Following Anesthesia, Sequela
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Thyroid and Parathyroid Surgery
- Malaria,Falciparum
- Chemotherapy-Induced Neutropenia
- Serum Albumin Low
- Visual Attention Span Deficit
- Testicular Teratoma
- Deformity Flexion
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Puberty, Delayed
- Gray Platelet Syndrome
- Blepharospasm of Both Eyelids
- Vibration; Exposure
- Advance Directive Completion
- Immunologically-induced Lung Disease
- Huntington Chorea
- View Full List
Drug Interventions
- Rovalpituzumab tesirine
- Pegfilgrastim
- S-Adenosyl-Methionine
- Pemetrexed
- Ebselen
- Celecoxib
- Vosaroxin
- F520
- Sorafenib
- MMV390048 120mg
- Oxycodone
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Bimatoprost 0.03% eye drops
- Cyanoacrylate
- Furmonertinib 160 mg
- Standard medical therapy
- ABY-035 i.v.
- Acalabrutinib in combination with VR
- Cytisine
- Mineralocorticoid receptor antagonist
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Argentina
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Congo
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Finland
- Contract Research Organizations in India
- Contract Research Organizations in Peru
- Contract Research Organizations in Serbia
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Venezuela
- CRO list by country